The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension.

Martin Keppel* (First author), Grzegorz Piecha, Winfried März, Janne Cadamuro (Co-author), Simon Auer (Co-author), Thomas Felder (Co-author), Cornelia Mrazek (Co-author), Hannes Oberkofler, Christian Trummer, Martin R Grübler, Verena Schwetz, Nicolas Verheyen, Marlene Pandis, Valentin Borzan, Elisabeth Haschke-Becher (Co-author), Andreas Tomaschitz, Stefan Pilz

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

7 Citations (Web of Science)
Original languageEnglish
Pages (from-to)e0212973
JournalPLOS ONE
Volume14
Issue number2
DOIs
Publication statusPublished - 2019

Keywords

  • MINERALOCORTICOID RECEPTOR ANTAGONIST
  • HIGH-SALT INTAKE
  • PRIMARY ALDOSTERONISM
  • DIABETIC-NEPHROPATHY
  • RENAL FIBROSIS
  • PROTEINURIA
  • BLOCKER
  • MODEL

Cite this